Table 3—

Variables related to the development of microvascular complications in type 2 diabetes by multinominal logistic regression analysis

VariablesAny microvascular complication
Retinopathy
Neuropathy
(Micro)albuminuria
POR (95% CI)POR (95% CIPOR (95% CI)POR (95% CI)
Skin AF<0.0012.02 (1.45–2.81)0.321.21 (0.83–1.74)0.0261.50 (1.05–2.14)<0.0011.88 (1.36–2.61)
Sex0.020.55 (0.33–0.90)0.910.97 (0.53–1.75)0.781.09 (0.61–1.93)0.0010.42 (0.25–0.71)
A1C0.0041.30 (1.09–1.55)0.131.18 (0.95–1.45)0.871.02 (0.82–1.26)0.0341.21 (1.01–1.44)
Diabetes duration0.661.01 (0.96–1.06)<0.0011.10 (1.06–1.15)0.0321.04 (1.00–1.08)0.040.95 (0.90–0.997)
Smoking0.070.56 (0.29–1.05)0.090.48 (0.21–1.11)0.0110.29 (0.11–0.75)0.961.02 (0.56–1.85)
Systolic blood pressure0.431.01 (0.99–1.02)0.391.01 (0.99–1.02)0.491.01 (0.99–1.02)0.181.01 (0.996–1.02)
LDL cholesterol0.481.09 (0.85–1.40)0.660.93 (0.69–1.27)0.350.87 (0.64–1.17)0.301.15 (0.89–1.49)
HDL cholesterol0.260.62 (0.27–1.43)0.360.63 (0.23–1.70)0.0810.41 (0.15–1.12)0.400.38 (0.15–0.96)
Triglycerides0.540.94 (0.78–1.14)0.410.91 (0.72–1.15)0.850.98 (0.79–1.22)0.190.87 (0.71–1.07)
BMI0.271.03 (0.98–1.08)0.331.03 (0.97–1.09)0.560.98 (0.93–1.04)0.391.02 (0.97–1.08)
  • AF, autofluorescence measured with the autofluorescence reader (see research design and methods).